AI
Afsheen Iqbal
Physician · Memorial Sloan Kettering Monmouth
Credentials: · · · ·
History
Research
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
Annals of Oncology · 2019 · 351 citations
COVID-19 in patients with lung cancer
Annals of Oncology · 2020 · 191 citations
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Nature Medicine · 2022 · 152 citations
- MK
10 papers
- GR
9 papers
- HY
7 papers
- JE
6 papers
5 papers
- IP
5 papers
- PP
5 papers
- AR
4 papers
